NCT05566197

Nusantara Diet (Low Calorie and Low Sodium) for Metabolic Syndrome

Status unknown NA Last updated 4 October 2022

What this trial tests

NA trial testing Diet Nusantara in Metabolic Syndrome in 50 participants. Status unknown.

Timeline

15 July 2022

Primary endpoint
30 December 2022

1 February 2023

Quick facts

Lead sponsor	Hasanuddin University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	50
Start date	15 July 2022
Primary completion	30 December 2022
Estimated completion	1 February 2023
Sites	1 location across Indonesia

Drugs / interventions tested

• Diet Nusantara
• Nutrition Counseling

Conditions studied

• Metabolic Syndrome — all drugs for Metabolic Syndrome →
• Diabetes — all drugs for Diabetes →
• Hyperlipidemias — all drugs for Hyperlipidemias →

Sponsor

Hasanuddin University

Who can join

Adults 18 to 60, any sex, with Metabolic Syndrome or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomized clinical trial is to evaluate the effect of Nusantara Diet (Low Calorie and Low Sodium) for Metabolic Syndrome. The main questions it aims to answer are:

* How effective the Nusantara diet in reducing body mass index and body fat percentage?
* How effective the Nusantara diet in affecting lipid profile and insulin resistance?

Participants will be given this diet for a period of 56 days and undergo repeated outcome measurement. This study has a comparison group (no intervention) to see the difference of reduction or slope of changes in outcomes. We assumed that the Nusantara diet will reduce the metabolic syndrome indicators (anthropometry, lipid profile, and insulin resistance profile).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.